Financial statements Adapharm

Balance sheet of Adapharm

Company age:
Age:
11 y. 5 m. 26 d.
Share capital:
Share capital:
200 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of ADAPHARM

Year
2018
2019
2020
2021
2022
2023
Total assets 14 892 545,28 14 295 427,19 17 585 495,38 20 092 931,25 18 815 612,84 15 648 933,08
A. Fixed assets 4 792 495,77 4 674 954,38 4 400 419,43 4 183 092,02 4 115 531,70 485 837,73
B. Current assets 10 100 049,51 9 620 472,81 13 185 075,95 15 909 839,23 14 700 081,14 15 163 095,35
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 14 892 545,28 14 295 427,19 17 585 495,38 20 092 931,25 18 815 612,84 15 648 933,08
A. Equity 4 549 951,84 5 630 123,75 6 548 246,18 8 901 538,40 8 773 514,81 4 123 677,95
B. Liabilities and provisions for liabilities 10 342 593,44 8 665 303,44 11 037 249,20 11 191 392,85 10 042 098,03 11 525 255,13
I. Long-term liabilities 4 178 790,79 3 134 669,54 5 268 987,70 2 377 471,62 917 669,00 0,00
II. Short-term liabilities 5 961 376,65 5 383 871,40 5 633 988,50 8 667 969,23 8 982 844,03 10 931 159,78
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.